Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.83 EUR | -0.95% |
|
-9.59% | -4.38% |
06-05 | MEDESIS : Invest Securities confirms its 'neutral' rating | CF |
2023 | Medesis Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Business Summary
The company's portfolio includes a drug candidate used to optimize cancer radiotherapy, 2 drug candidates used in the treatment of neurodegenerative diseases (Alzheimer's disease and Huntington's disease) and 2 drug candidates used in the treatment of radioactive contamination following a civil or military nuclear accident (Plutonium decorporation and cesium decorporation).
Number of employees: 10
Sales per Business
EUR in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -9.35% |
Sales per region
EUR in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -9.35% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 03-04-02 | |
Solene Guilliot
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Mario Alcaraz
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 19-06-11 | |
Robert Alonso
BRD | Director/Board Member | - | 22-10-26 |
Walt Linscott
BRD | Director/Board Member | 63 | 22-10-26 |
Olivier Connes
CHM | Chairman | - | 18-09-25 |
Director/Board Member | - | 15-06-29 | |
Cédric Navas
BRD | Director/Board Member | - | 18-09-25 |
Emmanuel Hebert
BRD | Director/Board Member | - | 19-06-11 |
Director/Board Member | - | 21-06-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,429,081 | 3,586,229 ( 80.97 %) | 0 | 80.97 % |
Company contact information
Medesis Pharma SA
L'Orée des Mas avenue du Golf
34670, Baillargues
+33 4 67 03 03 96
http://www.medesispharma.com![address Medesis Pharma S.A.(ALMDP)](https://cdn.zonebourse.com/static/address/118558649.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-4.38% | 3.94M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- ALMDP Stock
- Company Medesis Pharma S.A.